New Zealand markets close in 6 hours 48 minutes

Amylyx Pharmaceuticals, Inc. (AMLX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.7550-0.1350 (-7.14%)
At close: 04:00PM EDT
1.7798 +0.02 (+1.41%)
After hours: 07:54PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
170,201
62,526
50,191
12,877
Other short-term investments
201,161
284,419
45,927
0
Total cash
371,362
346,945
96,118
12,877
Net receivables
40,050
15,306
0
-
Inventory
38,323
9,769
0
-
Other current assets
14,931
10,113
5,392
-
Total current assets
464,666
382,133
104,951
13,639
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
8,039
8,675
527
152
Accumulated depreciation
-1,628
-540
-53
-1
Net property, plant and equipment
6,411
8,135
474
151
Other long-term assets
46,377
1,185
189
314
Total non-current assets
52,788
9,320
663
465
Total assets
517,454
391,453
105,614
14,104
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
22,061
6,257
4,372
3,613
Accrued liabilities
40,934
23,081
8,744
1,858
Other current liabilities
-
4,596
-
-
Total current liabilities
82,042
46,609
17,396
7,326
Non-current liabilities
Long-term debt
-
-
-
1,425
Deferred revenues
-
-
-
14
Total non-current liabilities
1,980
4,237
239,386
73,503
Total liabilities
84,022
50,846
256,782
80,829
Stockholders' equity
Common stock
7
7
1
1
Retained earnings
-304,949
-354,220
-155,845
-67,914
Accumulated other comprehensive income
197
-86
9
0
Total stockholders' equity
433,432
340,607
-151,168
-66,725
Total liabilities and stockholders' equity
517,454
391,453
105,614
14,104